Detalhe da pesquisa
1.
Polatuzumab Vedotin in Previously Untreated Diffuse Large B-Cell Lymphoma.
N Engl J Med
; 386(4): 351-363, 2022 01 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-34904799
2.
Ibrutinib plus Bendamustine and Rituximab in Untreated Mantle-Cell Lymphoma.
N Engl J Med
; 386(26): 2482-2494, 2022 06 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-35657079
3.
Polatuzumab vedotin in previously untreated DLBCL: an Asia subpopulation analysis from the phase 3 POLARIX trial.
Blood
; 141(16): 1971-1981, 2023 04 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36626583
4.
Golidocitinib, a selective JAK1 tyrosine-kinase inhibitor, in patients with refractory or relapsed peripheral T-cell lymphoma (JACKPOT8 Part B): a single-arm, multinational, phase 2 study.
Lancet Oncol
; 25(1): 117-125, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38092009
5.
Germline variants of DNA repair and immune genes in lymphoma from lymphoma-cancer families.
Int J Cancer
; 155(1): 93-103, 2024 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38446987
6.
Camrelizumab plus gemcitabine and oxaliplatin for relapsed or refractory classical Hodgkin lymphoma: a phase II trial.
BMC Med
; 22(1): 107, 2024 Mar 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38454451
7.
Deciphering the pivotal role of people with high-frequency occupational animal exposure in antibiotic resistance transmission between humans and animals.
J Antimicrob Chemother
; 79(1): 27-35, 2024 Jan 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37944030
8.
Zanubrutinib in relapsed/refractory mantle cell lymphoma: long-term efficacy and safety results from a phase 2 study.
Blood
; 139(21): 3148-3158, 2022 05 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-35303070
9.
Phase I study of the Syk inhibitor sovleplenib in relapsed or refractory mature B-cell tumors.
Haematologica
; 2024 Jan 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38235512
10.
Immunotyping of peripheral blood lymphocytes by flow cytometry reveals Th cell as a potential prognostic biomarker for extranodal NK/T-cell lymphoma.
Ann Hematol
; 103(5): 1643-1653, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38191717
11.
Clinical features, prognostic stratification, and treatment of advanced-stage non-nasal type extranodal natural killer/T-cell lymphoma: a multi-institutional real-world study.
Ann Hematol
; 103(1): 163-174, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37817010
12.
Tislelizumab and radiation therapy in low-risk early-stage extranodal natural killer/T-cell lymphoma, nasal type: a phase II study protocol.
Future Oncol
; 20(5): 245-256, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38018460
13.
Adaptively leverage multiple real-world data sources for treatment effect estimation based on similarity.
J Biopharm Stat
; : 1-11, 2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38557411
14.
Intensive therapy can improve long-term survival in newly diagnosed, advanced-stage extranodal NK/T-cell lymphoma: A multi-institutional, real-world study.
Int J Cancer
; 153(9): 1643-1657, 2023 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37539660
15.
Systematic Discovery of a New Catalogue of Tyrosine-Type Integrases in Bacterial Genomic Islands.
Appl Environ Microbiol
; 89(2): e0173822, 2023 02 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-36719242
16.
Indirect comparisons of efficacy of zanubrutinib versus orelabrutinib in patients with relapsed or refractory chronic lymphocytic leukemia/small lymphocytic lymphoma or relapsed or refractory mantle cell lymphoma.
Invest New Drugs
; 41(4): 606-616, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37420136
17.
Evidence of cure for extranodal nasal-type natural killer/T-cell lymphoma with current treatment: an analysis of the CLCG database.
Haematologica
; 108(9): 2467-2475, 2023 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36951150
18.
Long-term outcomes of relmacabtagene autoleucel in Chinese patients with relapsed/refractory large B-cell lymphoma: Updated results of the RELIANCE study.
Cytotherapy
; 25(5): 521-529, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36842849
19.
Hematological Oncology journal women in lymphoma special issue: Latest updates in nodal peripheral T-cell lymphoma.
Hematol Oncol
; 2023 Jun 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-37309261
20.
Improved method to stratify lymphoma patients with risk of secondary central nervous system involvement: A multicenter retrospective analysis.
Hematol Oncol
; 41(2): 239-247, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-34564882